During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...
Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children ...
GlobalData on MSN15h
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatmentThe US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for amyotrophic ...
T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...
Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback